UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported):
(Exact Name of Registrant as Specified in its Charter) |
|
| |||
(State of incorporation) |
| (Commission File Number) |
| (IRS Employer Identification No.) |
|
| |
(Address of principal executive offices) |
| (Zip Code) |
(
(Registrant’s telephone number, including area code)
Azar International Corp.
(Former Name or former address if changed from last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered under Section 12(g) of the Exchange Act: None |
Securities registered pursuant to Section 12(b) of the Act: None
Title of each class |
| Trading Symbol(s) |
| Name of each exchange on which registered |
N/A |
| N/A |
| N/A |
Item 5.03 Amendments to Articles of Incorporation or By-Laws; Change in Fiscal Year.
On August 17, 2022, Azar International Corp. (the “Company”), amended its articles of incorporation change its name to QLY Biotech Group Corp. (the “Name Change”). The change was made in anticipation of entering into a new line of business operations. Also on August 17, 2022, the Company increased its authorized shares of common stock to 1,000,000,000.
Item 8.01. Other Events
On August 23, 2022, FINRA declared the Name Change. Also on July 28, 2022, the Company was informed by FINRA that the Company’s ticker symbol would be changed to LQLY in twenty business days.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| ||
104 |
| Cover Page Interactive Data File (embedded within the Inline XBRL document) |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
October 11, 2022
QLY BIOTECH GROUP CORP. |
| |
|
|
|
| /s/ Yang, Lixue |
|
By: | YANG, LIXUE |
|
Title: | CEO |
|
| 3 |